Introduction
Obstructive sleep apnea (OSA) is a potentially serious sleep disorder characterized by recurrent episodes of breathing cessation during sleep secondary to an upper airway collapse (1) . Complete apnea or partial hypopnea episodes can last from 10-30 seconds and may occur up to hundreds of times nightly. It is often accompanied with swings in heart rate, a decrease in oxygen saturation, and brief electroencephalogram arousals.
Sleep apnea is a disorder not commonly diagnosed by the ophthalmologist, but an important one that has many systemic and ocular complications. Furthermore, it is undertreated as patients defer treatment with a continuous positive airway pressure (CPAP) mask, however, it can be reversed quickly with appropriate treatment. Sleep apnea carries significant morbidity with a higher incidence of cardiovascular and cerebral sequelae (2) (3) . It is associated with hypertension, diabetes, coronary artery disease, congestive heart failure (4) (5) , atrial fibrillation (6) ; all of which may predispose one to a stroke. Additionally, OSA has also recently been identified as an independent risk factor for stroke (7) ••. There is also increasing evidence that OSA coexists in epilepsy and that CPAP treatment improves seizure control, cognitive performance and quality of life (8) .
Epidemiology
Sleep apnea is an increasingly prevalent condition in both adults and children. Approximately 24% of men and 9% of women have OSA, with and without excessive daytime sleepiness (9) . In children, OSA is a common but underdiagnosed condition, where the exact prevalence is less certain. One study suggested approximately 6% of adolescents may have sleep-related disordered breathing (10) . Many of these children present with obesity and excessive daytime sleepiness and/or hyperactivity.
Pathophysiology
An anatomical deficiency of the upper airway is regarded as the most accepted theory regarding the pathogenesis of OSA. Schwab et al. explained the increase soft tissue volume of soft palate, tongue, parapharyngeal fat pads and lateral pharyngeal walls (11) (12) (13) . Patients with OSA seem to also have a smaller and an oval shaped pharyngeal airway with the long axis in the anterior-posterior orientation as opposed to the short axis in the anterior-posterior orientation when compared to healthy subjects. Longer airways are more easily collapsible than shorter airways and this recurrent pharyngeal collapse directly obstructs the upper airway.
Predisposing factors
Excess weight and fat deposit around the upper airway may obstruct breathing. An increase in neck circumference may also narrow the airway. A neck circumference greater than 17 inches (43 centimeters) for males and 15 inches (38 centimeters) for females is associated with an increased risk. Chronic nasal congestion can also narrow the upper airway. There is a relative increase in risk with hypertension and a three-fold increase in patients with diabetes. Men are twice as likely as women to develop sleep apnea.
Among people under the age of 35, OSA is more common in blacks, Hispanics and Pacific Islanders.
Sleep apnea is three times more common in adults over the age of 65. Menopause appears to increase the risk in females. Smokers have a three-fold increase than non-smokers and alcohol intake increases the risk by relaxing the muscles in the throat.
Clinical Manifestations
The three cardinal symptoms of OSA include loud snoring, excessive daytime sleepiness and apnea episodes. Observed episodes of breathing cessation during sleep and abrupt awakenings accompanied by shortness of breath are common complaints. Other features include awakening with a dry mouth or sore throat, morning headache, frequent urination at night and insomnia.
Diagnosis
The Epworth sleepiness scale is widely used as a screening test for OSA at a cutoff of 10 points (14) .
Tests to detect sleep apnea include nocturnal polysomnography, oximetry and portable cardiorespiratory testing. During nocturnal polysomnography testing, the physician can monitor the functions of the heart, lungs and brain as well as rule out other conditions that can cause excessive daytime sleepiness. Pulse oximetry readings will often be low during apnea with normalization upon awakening. A portable cardiorepiratory testing device provides the patient the ability with a take-at-home test that measures oximetry, along with airflow and breathing pattern measurements.
Management

Medical management
Treatment with CPAP quickly reverses symptoms of excessive daytime sleepiness and aids in management of OSA. Continuous positive pressure, applied through a nasal mask, oronasal mask, or nasal pillows, acts as a pneumatic splint to maintain upper airway patency during sleep. Adequate treatment with CPAP has been demonstrated to show an over-recruitment of brain regions compared with controls using functional MRI scanning (15) •. For patients who cannot tolerate CPAP therapy, bilevel positive airway pressure (BiPAP) therapy is attempted next, which automatically adjusts the pressure while one is sleeping. An oral appliance device is attempted if BiPAP is not tolerable to open the throat by bringing the jaw forward. Additionally, modafinil 200-400mg/day has been shown to effectively enhance alertness in patients with daytime somnolence (16) .
Surgical management
Surgical management is reserved for patients in whom medical treatment cannot be tolerated or has failed. Uvulopalatopharyngoplasty is the most common surgical procedure performed for adults with sleep apnea. It involves the removal of the tonsils, the uvula, the distal margin of the soft palate and the redundant pharyngeal tissue along with reshaping of the lateral pharyngeal walls. Genioglossus muscle advancement with hyoid myotomy can also be used to expand the upper airway. Maxillomandibular advancement osteotomy is usually reserved for patients in whom other surgical modalities fail. The airway is expanded as the midface, palate, and mandible are moved forward. Finally, although a tracheostomy may be the most effective, it is only reserved for patients with severe, life-threatening OSA in whom other surgical treatments have all failed. Somnoplasty, or radiofrequency volumetric tissue reduction of the soft palate, has recently generated much interest in treating OSA (17) . Mojon et al. has hypothesized several theories in a correlation between OSA and NAION. An ischemic event may be secondary to impaired optic nerve head blood flow autoregulation from apnea. Optic nerve vascular dysregulation may also be a result of variations in arterial blood pressure seen in OSA, which may be due to an imbalance between nitric oxide and endothelin. Additionally, direct damage by periods of hypoxia likely plays a role (25, 28) . Older studies had noted visual field defects consistent with an optic neuropathy in patients with OSA, however, data had not demonstrated a direct causal relationship between OSA and visual field defects (28) . Mojon men and 655 women, with sleep apnea. This is the largest study to date of IIH in men. Men were more likely to have OSA (24% vs. 4%) than women. Also, men were almost twice as likely to develop visual changes (35% vs. 20%) and had fewer symptoms of headache (55% vs. 75%) as compared to women.
Associated Ocular Disorders Floppy eyelid syndrome
Non-Arteritic Ischemic Optic Neuropathy
The debate will continue if whether OSA is causal or a comorbidity amongst patients with IIH. If causal, we still do not have a plausible mechanism (40) . Additional questions, as if the visual outcome in patients with increased ICP is affected by the presence of OSA needs to be looked at in future studies.
Screening however, is recommended in all patients with OSA who may have visual symptoms (31) .
Central Serous Chorioretinopathy
Patients with sleep apnea have increased levels of circulating epinephrine and norepinephrine. With elevated levels of catecholamines, OSA has been hypothesized to be a direct risk factor for central serous 
Retinal Vein Occlusion
Leroux les Jardins et al. recently investigated the association between retinal vein occlusions and OSA.
They are the first to report three patients who presented with retinal vein occlusions and found to have OSA. They hypothesized, that retinal vein occlusions may be associated with OSA as they may be secondary to a slow-down of blood flow circulation secondary to hypoxemia and elevated nocturnal intracranial pressure. Strictly acting on the retinal microcirculation, OSA may directly have a causal effect on retinal vein occlusions (44) .
Conclusion
